December 17, 2012
Nordic Nanovector announces inclusion of first patient in Betalutin™ Phase 1 trial and receipt of NOK 1 million in research funding.

See link for details. 

November 2, 2012
Nordic Nanovector is pleased to announce that Tone Kvåle has joined the company as Chief Financial Officer as of November 1, 2012. 
See link for details.

October 17, 2012
Nordic Nanovector AS Receives Regulatory Approval to Proceed With Phase 1/2 Clinical Trial in Norway.  

See link for details.

August 24, 2012
Nordic Nanovector AS receives regulatory approval to proceed with Phase 1/2 clinical trial in Sweden.

See link for details.

June 3, 2012
Nordic Nanovector is pleased to announce that experienced QA & QP Anniken Hagen has joined the company to head up its quality assurance and regulatory affairs initiatives.
See link for details.

January 22, 2012
Nordic Nanovector AS raises 14.3 MNOK in a private placement.
See link for details.